Zobrazeno 1 - 10
of 2 982
pro vyhledávání: '"Allograft dysfunction"'
Publikováno v:
Alexandria Journal of Medicine, Vol 60, Iss 1, Pp 249-258 (2024)
Background Chronic allograft dysfunction (CAD) represents a complex process of inflammatory response, fibrosis, and tissue restoration, mediated by a myriad of proinflammatory cytokines, enzymes, and growth factors. NOD-like receptor protein3 (NLRP3)
Externí odkaz:
https://doaj.org/article/81b297e748a548ce964ff11c33624852
Autor:
Christian Martin, Kathleen S. Mahan, Talia D. Wiggen, Adam J. Gilbertsen, Marshall I. Hertz, Ryan C. Hunter, Robert A. Quinn
Publikováno v:
Microbiome, Vol 12, Iss 1, Pp 1-12 (2024)
Abstract Background Progression of chronic lung disease may lead to the requirement for lung transplant (LTx). Despite improvements in short-term survival after LTx, chronic lung allograft dysfunction (CLAD) remains a critical challenge for long-term
Externí odkaz:
https://doaj.org/article/f2779c4e36f2402580fa37a1dee2c5bf
Perceptions of Palliative Care Among Patients With Kidney Allograft Dysfunction: A Qualitative Study
Autor:
Cameron E. Comrie, Katherine He, Jolene Wong, Anil K. Chandraker, Naoka Murakami, Joshua R. Lakin, Amanda J. Reich
Publikováno v:
Kidney Medicine, Vol 6, Iss 12, Pp 100917- (2024)
Rationale & Objective: Nearly half of kidney transplant recipients develop allograft failure within 10 years of transplantation and experience high mortality, significant symptom burden, and complex communication challenges. These patients may benefi
Externí odkaz:
https://doaj.org/article/52b49e30990847ee8015ff1495c5246c
Autor:
Zhonghao Xie, Xiaohong Lin, Yan Wang, Zhitao Chen, Ping Zeng, Xiaoshun He, Weiqiang Ju, Maogen Chen
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Background Circulating cytokine levels not only correlate with the progression of liver disease but also serve as indicators for the infection status of the body. Growing evidence points to the connection between donor cytokines and graft function fo
Externí odkaz:
https://doaj.org/article/c1282f3e16db4a34a352ee63c7ff2979
Publikováno v:
JHLT Open, Vol 6, Iss , Pp 100141- (2024)
Background: Plasma percent donor-derived cell-free DNA (%dd-cfDNA) has been investigated as a biomarker of allograft injury after lung transplantation. We sought to determine the clinical utility of %dd-cfDNA as a screen for acute cellular rejection
Externí odkaz:
https://doaj.org/article/b88e0f61687546be9c70f9d83c3f974f
Autor:
Xin Shao, Zheng Wang, Kai Wang, Xiaoyan Lu, Ping Zhang, Rongfang Guo, Jie Liao, Penghui Yang, Shusen Zheng, Xiao Xu, Xiaohui Fan
Publikováno v:
Engineering, Vol 36, Iss , Pp 193-208 (2024)
Liver transplantation (LT) is the standard therapy for individuals afflicted with end-stage liver disease. Despite notable advancements in LT technology, the incidence of early allograft dysfunction (EAD) remains a critical concern, exacerbating the
Externí odkaz:
https://doaj.org/article/7c0dff11888c41bcb28d98af71eb38a8
Autor:
Mary A. Neal, PhD, Saskia Bos, MD, PhD, Charlotte W. Holland, MRCP, Kieren G. Hollingsworth, Gerard Meachery, FRCP, Arun Nair, MD, FRCP, James L. Lordan, FRCP, Andrew J. Fisher, FRCP, PhD, Peter E. Thelwall, PhD
Publikováno v:
JHLT Open, Vol 7, Iss , Pp 100167- (2025)
Background: By the time chronic lung allograft dysfunction (CLAD), with its main phenotypes bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS), is diagnosed by pulmonary function testing, irreversible damage to the lung
Externí odkaz:
https://doaj.org/article/b3d1eca48bfe4574a1daa60f1cc0877f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kyoto Matsudo, Shinkichi Takamori, Tomoyoshi Takenaka, Mototsugu Shimokawa, Asato Hashinokuchi, Taichi Nagano, Fumihiko Kinoshita, Takaki Akamine, Mikihiro Kohno, Gouji Toyokawa, Tomoharu Yoshizumi
Publikováno v:
Transplant International, Vol 37 (2024)
Bronchiolitis obliterans syndrome (BOS) is a chronic complication following lung transplantation that limits the long-term survival. Although the enhancer of zeste homolog 2 (EZH2) is involved in post-transplantation rejection, its involvement in BOS
Externí odkaz:
https://doaj.org/article/dce38c74c0ee4660b3f58facc7fa95e4